BioScrip (BIOS) Tops Q3 Views
More News related to BIOS
- BioScrip, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference
- BioScrip, Inc. to Present at Credit Suisse 18th Annual Healthcare Conference
- BioScrip (BIOS) Posts Q3 EPS of $0.14, Tops by 4c
- Trading Radar for 10/30: Sony (SNE), Penske (PAG), Alcatel-Lucent (ALU) Report
- Trading Review for Allion Healthcare Inc. Issued by Beacon Equity
More News related to Earnings
- Wilshire Enterprises (WOC) Announces Resignation of COO
- Ross Stores (ROST) Restructures Senior Management
- Illinois Tool Works (ITW) Names David B. Smith, Jr. to Board
- Dell (DELL) Appoints Ross Perot Jr. to Board
- Huntington Bancorp. (HBAN) Names David Anderson to EVP and Controller
BioScrip, Inc. (Nasdaq: BIOS) reports Q3 EPS of $0.06, ex-items, 1 cent better than the analyst estimate of $0.05. Revenue for the quarter was $359.4 million, versus the consensus of $356.99 million.
BioScrip, Inc., a specialty pharmaceutical healthcare organization, provides medications and management solutions for chronic and other healthcare conditions in the United States.
Related Categories
EarningsStocks Mentioned
+0.22Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
